About Us

Yee Kwang leads BMSIPO with a passion for translating the public research and innovation efforts across Singapore to forge impactful and outcome-driven partnerships with industry.  He has a keen interest in understanding opportunities that future advances in science and technology could bring in disrupting or transforming current industry landscapes.  Yee Kwang also leads business intelligence and development at the Singapore Translational Cancer Consortium.

Previously, he was at the Singapore Economic Development Board, in various industry and policy roles. This included a stint at the Human Capital Leadership Institute, where he was Head of Partnership Development.

He has a Bachelor’s and Master’s degree in Electrical Engineering from the University of Illinois at Urbana Champaign, and the University of California, Santa Barbara. His Master’s research focus was on compound semiconductor device modelling. He also holds a Graduate Certificate of Intellectual Property Law from the IP Academy.

Pearlyn supports the BMSIPO team on administrative matters.

She was previously an Executive Secretary to the Deputy Chief Executive (Academic & Clinical Planning office), at National University Health System. Before that, she was a Senior Secretary and Administration and Facilities Leader at Eli Lilly’s clinical research unit.

Pearlyn holds a Graduate Diploma in Human Resource from the Management Development Institute of Singapore, and a Diploma in Management Studies from SIM Global Education.

Amber supports ecosystem development and programme design across healthcare R&D and enterprise initiatives, working closely with public sector and clinical stakeholders. She also serves as a Research Ethics Institutional Board Member for NHG Health.

Prior to joining BMSIPO, Amber built and led innovation evaluation and implementation frameworks at Tan Tock Seng Hospital, where she provided guidance on medtech clinical and implementation study design, pathfinding, and adoption planning for exploratory solutions. She also strategised and designed regional startup ecosystem programmes at APACMed, and brings deep expertise in research ethics and biomedical regulations from her work within the National Healthcare Group.

Amber obtained a Bachelor of Science in Nursing from the National University of Singapore.

Claire works on Singapore’s biomedical ecosystem-wide initiatives.  In addition, she supports the BioPharma team.

Previously, she was Section Managing Editor at an academic publishing institute, focusing on editorial work and engaging with academics internationally.

Claire graduated with a Bachelor of Science (Honours) in Chemistry and a minor in Forensic Science. She further pursued multi-omics research in biomedical applications, graduating with a PhD from the National University of Singapore Graduate School, Integrative Sciences and Engineering Programme.

Denise supports the Medtech team at BMSIPO, while concurrently overseeing Corporate Planning and Strategy at the Diagnostics Development Hub (DxD Hub)—an end-to-end productisation partner that accelerates the development of diagnostics and digital health solutions.

She holds a Bachelor of Science (Hons) from the National University of Singapore, with a double major in Life Sciences and Psychology.

Farah focuses on cardiovascular, metabolic and endocrine research programmes. In addition, she supports multi-institutional research programs such as the Asian neTwork for Translational Research and Cardiovascular Trials: Human Imaging, Genetics and Biomarkers Study (ATTRaCT).

Prior to joining BMSIPO, Farah was at the A*STAR’s Institute of Bioengineering and Bioimaging, where she was involved in developing and managing various biotech-related academic projects and industry collaborations. Farah has a PhD in Biomedical Applications of In Vitro Systems, and a Bachelor of Life Sciences from the National University of Singapore.

Pei Ling focuses on building strategic engagements between local research performers and key pharmaceutical MNCs.

Previously, Pei Ling was a scientist at the Institute of Molecular and Cell Biology (IMCB), where she conducted research in the field of cancer therapeutics. She engages various stakeholders in the startup ecosystem to help in their science communication efforts. Pei Ling is also a published freelance science writer.

Pei Ling obtained her BSc in Biochemistry and Molecular Biology from Brown University before receiving her PhD in Biomedical Sciences (Cancer Biology) from the Icahn School of Medicine at Mount Sinai.

Jolene is part of the Therapeutics team, managing strategic engagements with key pharmaceutical MNCs and supporting their collaborations across Singapore’s research and clinical ecosystem.

Prior to joining BMSIPO, Jolene trained as a Scientist at NTU LKCMedicine, focusing on interdisciplinary research in bone tissue engineering and regenerative medicine.

Jolene obtained both her Bachelor’s degree in Bioengineering and her PhD through the Interdisciplinary Graduate Programme at Nanyang Technological University.

As part of the Therapeutics team at BMSIPO, Xun Hui builds strategic engagements and supports research and industry partnerships between Pharma MNCs, foreign and local Biotech companies and research organisations.

Previously, Xun Hui was a Scientist at the Experimental Drug Development Centre (EDDC) where she focused on target discovery and early-stage preclinical drug development of both small and large molecules in Oncology and Inflammation & Immunology. Prior to that, she was the business development manager at a local biotech company, overseeing initiatives to advance the company’s growth and industry partnerships.

Xun Hui earned a BSc in Biological Sciences (Hons) from Nanyang Technological University before receiving her PhD in Cancer Biology from the Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore.

Germaine works closely with pharma and biotech companies, helping them to establish win-win partnerships with research institutions.

She started as a Research Officer at Professor Giulia Adriani’s laboratory in A*STAR’s Singapore Immunology Network (SIgN). Besides laboratory management, she worked on the development of 3D tumour models using microfluidic devices.

Germaine obtained her Bachelor’s Degree in Life Sciences (Honours) from the National University of Singapore.

Shi Yun leads the Medtech team at BMSIPO where she facilitates research and innovation partnerships in Medtech with strategic industry partners and public sector research, clinical and academic institutions. In addition, she also leads corporate and strategic planning at the Diagnostics Development Hub.

Prior to her role at BMSIPO, Shi Yun was at the A*STAR Biomedical Research Council, where she was involved in the development and support of various Medtech-related grants and research programmes.

Shi Yun holds a Bachelor’s Degree in Biological Sciences from Nanyang Technological University and a PhD in Molecular Neuroscience from the National University of Singapore Graduate School for Integrative Sciences and Engineering.

Yu Ying focuses on medical devices such as clinical diagnostic equipment and implants.

She started as a Management Associate at Tan Tock Seng Hospital, where she was involved in optimising hospital operations, establishing of new medical facilities and events management. She then went on to ZEISS as a Product Consultant for cataract surgery.

Yu Ying holds a Bachelor of Science (Honours) in Life Sciences from National University of Singapore.

Mark’s work at BMSIPO is centred around diagnostics. Previously, he was Head of Science and Technology Research Scientist at Cell ID where he was involved in business development, technology transfer, and assay development.

He graduated with a Bachelor’s Degree in Biological Sciences from Nanyang Technological University and a PhD in Future Healthcare from the Interdisciplinary Graduate School, Nanyang Technological University.